JP2011519910A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519910A5
JP2011519910A5 JP2011508009A JP2011508009A JP2011519910A5 JP 2011519910 A5 JP2011519910 A5 JP 2011519910A5 JP 2011508009 A JP2011508009 A JP 2011508009A JP 2011508009 A JP2011508009 A JP 2011508009A JP 2011519910 A5 JP2011519910 A5 JP 2011519910A5
Authority
JP
Japan
Prior art keywords
ono
independently
alkyl
cycloalkoxy
alkoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508009A
Other languages
English (en)
Japanese (ja)
Other versions
JP5401540B2 (ja
JP2011519910A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/005594 external-priority patent/WO2009136281A1/en
Publication of JP2011519910A publication Critical patent/JP2011519910A/ja
Publication of JP2011519910A5 publication Critical patent/JP2011519910A5/ja
Application granted granted Critical
Publication of JP5401540B2 publication Critical patent/JP5401540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508009A 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類 Active JP5401540B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US61/052,084 2008-05-09
US13933308P 2008-12-19 2008-12-19
US61/139,333 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (3)

Publication Number Publication Date
JP2011519910A JP2011519910A (ja) 2011-07-14
JP2011519910A5 true JP2011519910A5 (enExample) 2012-03-15
JP5401540B2 JP5401540B2 (ja) 2014-01-29

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508009A Active JP5401540B2 (ja) 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類

Country Status (8)

Country Link
US (1) US8101658B2 (enExample)
EP (1) EP2274279B1 (enExample)
JP (1) JP5401540B2 (enExample)
CN (1) CN102099330B (enExample)
AR (1) AR076731A1 (enExample)
CA (1) CA2723704C (enExample)
ES (1) ES2428387T3 (enExample)
WO (1) WO2009136281A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6087147B2 (ja) * 2009-06-22 2017-03-01 ジョンソン、マッセイ、パブリック、リミテッド、カンパニーJohnson Matthey Public Limited Company プロスタグランジンの精製方法
WO2012112451A1 (en) * 2011-02-14 2012-08-23 Allergan, Inc. Ester derivatives of bimatoprost compositions and methods
US20150272988A1 (en) 2012-03-07 2015-10-01 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CA2871292A1 (en) 2012-05-31 2013-12-05 Theravance Biopharma R&D Ip, Llc Nitric oxide donor neprilysin inhibitors
US10280138B2 (en) 2015-03-31 2019-05-07 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
EP3347096A4 (en) 2015-09-09 2019-05-15 Advanced Inhalation Therapies (AIT) Ltd. STICK OXIDE INHALATION THERAPY FOR SMALL CHILDREN WITH BRONCHIOLITIS
BR112019009330A2 (pt) 2016-11-08 2019-07-30 Bausch & Lomb composto
ES2836118T3 (es) * 2018-02-21 2021-06-24 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
RU2718744C2 (ru) 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
US10688073B2 (en) * 2018-07-12 2020-06-23 Nicox Sa Ophthalmic compositions containing a nitric oxide releasing prostamide
EP3772511B1 (en) * 2019-08-05 2023-11-08 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue
ES3017242T3 (en) * 2021-02-03 2025-05-12 Nicox Sa Process for the preparation of a nitric oxide donating prostaglandin analogue
US20240390390A1 (en) 2021-09-20 2024-11-28 Nicox Sa Nitric oxide releasing prostamide as neuroprotective agent
CN119350280A (zh) * 2021-11-18 2025-01-24 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
EP4410294A3 (en) 2022-07-07 2024-11-06 Nicox S.A. Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药(常熟)有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
EP1480949B1 (en) * 2002-03-01 2015-04-29 Allergan, Inc. Preparation of prostamides
JP3984283B2 (ja) * 2004-01-05 2007-10-03 ニコックス,ソシエテ アノニム プロスタグランヂンニトロオキシ誘導体
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Similar Documents

Publication Publication Date Title
JP2011519910A5 (enExample)
RU2488582C2 (ru) Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение
JP2008525416A5 (enExample)
JP2010515731A5 (enExample)
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
JP2008255122A5 (enExample)
JP2007511546A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2013510857A5 (enExample)
JP2009504764A5 (enExample)
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
JP2010529147A5 (enExample)
JP2010510967A5 (enExample)
JP2008504265A5 (enExample)
JP2007510662A5 (enExample)
JP2007302689A5 (enExample)
JP2011529502A5 (enExample)
JP2011516511A5 (enExample)
JP2013515037A5 (enExample)
JP2010508310A5 (enExample)
JP2007502817A5 (enExample)
JP2010534246A5 (enExample)
JP2005517008A5 (enExample)
JP2012509265A5 (enExample)